CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airways disease

被引:48
作者
Bishop, B [1 ]
Lloyd, CM [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, Leukocyte Biol Sect, London SW7 2AZ, England
基金
英国惠康基金;
关键词
D O I
10.4049/jimmunol.170.9.4810
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
One of the characteristic features of allergic asthma is recruitment of large numbers of inflammatory cells including eosinophils and Th2 lymphocytes to the lung. This influx of inflammatory cells is thought to be a controlled and coordinated process mediated by chemokines and their receptors. It is thought that distinct, differential expression of chemokine receptors allows selective migration of T cell subtypes in response to the chemokines that bind these receptors. Th2 cells preferentially express CCR8 and migrate selectively to its ligand, CC chemokine ligand (CCL)1. We studied the role of the CCR8 ligand, CCL1, in the specific recruitment of Th2 cells and eosinophils to the lung in a murine model of allergic airway disease. We have demonstrated for the first time that CCL1 is up-regulated in the lung following allergen challenge. Moreover, a neutralizing Ab to CCL1 reduced eosinophil migration to the lung, but had no effect on recruitment of Th2 cells following allergen challenge. In addition, there was no change in airway hyperresponsiveness or levels of Th2 cytokines. In a Th2 cell transfer system of pulmonary inflammation, anti-CCL1 also failed to affect recruitment of Th2 cells to the lung following allergen challenge. Significantly, intratracheal instillation of rCCL1 increased recruitment of eosinophils but not Th2 cells to the lung in allergen-sensitized and -challenged mice. In summary, our results indicate that CCL1 is important for the pulmonary recruitment of eosinophils, rather than allergen-specific Th2 cells, following allergen challenge.
引用
收藏
页码:4810 / 4817
页数:8
相关论文
共 38 条
  • [1] Cutting edge: Eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils
    Bandeira-Melo, C
    Sugiyama, K
    Woods, LJ
    Weller, PF
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (08) : 4813 - 4817
  • [2] Bernardini G, 1998, EUR J IMMUNOL, V28, P582, DOI 10.1002/(SICI)1521-4141(199802)28:02<582::AID-IMMU582>3.0.CO
  • [3] 2-A
  • [4] Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
    Bonecchi, R
    Bianchi, G
    Bordignon, PP
    D'Ambrosio, D
    Lang, R
    Borsatti, A
    Sozzani, S
    Allavena, P
    Gray, PA
    Mantovani, A
    Sinigaglia, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) : 129 - 134
  • [5] Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes
    Chan, WL
    Pejnovic, N
    Lee, CA
    Al-Ali, NA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1238 - 1244
  • [6] Cheng HL, 2001, ONCOL REP, V8, P193
  • [7] Cohn L, 1998, J IMMUNOL, V161, P3813
  • [8] Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
    Corry, DB
    Folkesson, HG
    Warnock, ML
    Erle, DJ
    Matthay, MA
    WienerKronish, JP
    Locksley, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) : 109 - 117
  • [9] Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses
    Coyle, AJ
    Lloyd, C
    Tian, J
    Nguyen, T
    Erikkson, C
    Wang, L
    Ottoson, P
    Persson, P
    Delaney, T
    Lehar, S
    Lin, S
    Poisson, L
    Meisel, C
    Kamradt, T
    Bjerke, T
    Levinson, D
    Gutierrez-Ramos, JC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 895 - 902
  • [10] D'Ambrosio D, 1998, J IMMUNOL, V161, P5111